Clinical Trial Update: Tenofovir Disoproxil Fumarate in Combination of Hepatitis B Vaccine for Preventing Hepatitis B Vertical Transmission [Phase 4]

View source ↗

Summary

Phase 4 trial investigating Tenofovir Disoproxil Fumarate in combination with hepatitis B vaccine to prevent vertical transmission of hepatitis B.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Hepatitis B vaccine (Hepatitis B vaccine)
• TENOFOVIR DISOPROXIL FUMARATE (tenofovir disoproxil fumarate)

Snippet

Sponsor: New Discovery LLC | Conditions: Hepatitis B Infection, Congenital Malformation | Phase 4 | Status: UNKNOWN